Dermatology

An interview with Victoria Barrio, MD, and Fabiana Castro Porto Silva Lopes, MD, about the Society for Pediatric Dermatology and its efforts to address diversity in the dermatology field.

A list of the top stories covered this week in the dermatology field, with data on breakthroughs, new research, and advanced treatment options.

In recent research into alopecia areata treatments, selective JAK1 inhibition was tested as a means for restoring hair growth.

A recent research letter identified a correlation between mRNA vaccines for COVID-19 and cases of chronic spontaneous urticaria, although the connection requires further study.

In this recent study, mental health conditions associated with alopecia areata were assessed by the study’s investigators.

The latest HCPLive interview segment with Karan Lal, DO, discussing his views on what can go wrong during cosmetic procedures.

Shawn Kwatra, MD, and Sarina B. Elmariah, MD, PhD, share final pearls of wisdom for other physicians taking care of patients with prurigo nodularis (PN).

Experts in dermatology discuss unmet needs in prurigo nodularis (PN) and the importance of addressing those needs for disease management.

Drs Raj Chovatiya, Shawn Kwatra, and Sarina B. Elmariah review exciting new therapies in the treatment landscape of PN.

A new interview segment with Karan Lal, DO, in which he explores the benefits and drawbacks of dermatology offices versus medical spas.

After addressing a 2021 CRL, Verrica Pharmaceuticals vies for the agent to become the first drug approved to treat the common skin infection.

Experts in dermatology share thoughts on the need for additional investigative research of prurigo nodularis in order to better treat patients.

Raj Chovatiya, MD, PhD; Shawn Kwatra, MD; and Sarina B. Elmariah, MD, PhD, discuss potential challenges to the adoption of dupilumab in the treatment of PN.

A discussion with Henry Lim, MD, during an interview segment in which he described photoprotection measures for various skin phenotypes and his outlook on future research.

An HCPLive interview with Henry Lim, MD, during which he describes the differing needs of various skin types and the differences in sunscreen regulations.

An interview segment with Henry Lim, MD, on his presentation from Winter Clinical regarding different photoprotection measures for different phenotypes.

In a Q&A interview with Glynis Ablon, the dermatologist described highlights from her recent Winter Clinical presentation on new devices for clinical practice.

An overview of some of the biggest articles in the dermatology field covered this week, including new breakthroughs in research.

An interview segment featuring Lal’s experiences treating epidermolysis bullosa as well as his opinions on treatment and management.

Experts in dermatology discuss ideal candidates for dupilumab.

Drs Raj Chovatiya, Shawn Kwatra, and Sarina B. Elmariah review PRIME and PRIME 2 phase 3 studies of dupilumab for treatment of PN.

An interview with Karan Lal on his experiences treating patients facing the rare condition known as epidermolysis bullosa.

An FDA announcement on this topical gene therapy for DEB pushes back the PDUFA date to May of this year, accompanying a regulatory update.

A letter to the editor from China explored the various types of reactions to two types of vaccines for COVID-19.

A set of highlights from some of the more impactful research and data covered this past week in the dermatology field, covering breakthroughs in research and advanced treatment options.